Effect of polymorphism of apolipoprotein E and angiotensin-converting enzyme genes on arterial wall thickness

被引:90
作者
Kogawa, K [1 ]
Nishizawa, Y [1 ]
Hosoi, M [1 ]
Kawagishi, T [1 ]
Maekawa, K [1 ]
Shoji, T [1 ]
Okuno, Y [1 ]
Morii, H [1 ]
机构
[1] OSAKA CITY UNIV,SCH MED,DEPT INTERNAL MED 2,OSAKA 545,JAPAN
关键词
DENSITY LIPOPROTEIN CHOLESTEROL; INSERTION DELETION POLYMORPHISM; CORONARY HEART-DISEASE; MYOCARDIAL-INFARCTION; EPSILON-4; HOMOZYGOSITY; VASCULAR HYPERTROPHY; DIABETES-MELLITUS; CAROTID-ARTERY; RISK FACTOR; ATHEROSCLEROSIS;
D O I
10.2337/diabetes.46.4.682
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We examined the association between the polymorphism of the apolipoprotein E (apoE) and the ACE genes and the intima-media thickness (IMT) of the carotid and femoral arteries measured using ultrasonography. The values of IMT of each artery were significantly higher in NIDDM patients (n = 356) than in control subjects (n = 235). The E4 allele or the D allele did not affect clinical characteristics, including age, fasting plasma glucose, total cholesterol, HDL cholesterol, LDL cholesterol, or blood pressure, in NIDDM or control subjects. No difference in the carotid WIT value was noted among the apoE genotypes in control or diabetic subjects. The carotid IMT was significantly higher in diabetic patients with the DD genotype (1.200 +/- 0.586 mm) than in those with the II genotypes (0.990 +/- 0.364 mm). Neither the E4 allele nor the D allele affected the femoral IMT in control or diabetic subjects. Multiple regression analysis demonstrated that the carotid IMT of NIDDM patients was associated with age, the D allele, and LDL cholesterol but not with the E4 allele, whereas that of control subjects was associated with age, sex, systolic blood pressure, LDL cholesterol, and HDL cholesterol, inversely. These results suggested that the E4 allele was not associated with the carotid or femoral IMTs, but that the D allele was statistically associated with carotid IMT in NIDDM patients but not control subjects. However, since the association was weak (2.3% explanatory power), its biological significance remains to be determined.
引用
收藏
页码:682 / 687
页数:6
相关论文
共 35 条
[1]   PLASMA ANGIOTENSIN-CONVERTING ENZYME-ACTIVITY AND CAROTID WALL THICKENING [J].
BONITHONKOPP, C ;
DUCIMETIERE, P ;
TOUBOUL, PJ ;
FEVE, JM ;
BILLAUD, E ;
HERAUD, V .
CIRCULATION, 1994, 89 (03) :952-954
[2]   DELETION POLYMORPHISM IN THE GENE FOR ANGIOTENSIN-CONVERTING ENZYME IS A POTENT RISK FACTOR FOR MYOCARDIAL-INFARCTION [J].
CAMBIEN, F ;
POIRIER, O ;
LECERF, L ;
EVANS, A ;
CAMBOU, JP ;
ARVEILER, D ;
LUC, G ;
BARD, JM ;
BARA, L ;
RICARD, S ;
TIRET, L ;
AMOUYEL, P ;
ALHENCGELAS, F ;
SOUBRIER, F .
NATURE, 1992, 359 (6396) :641-644
[3]   ANGIOTENSIN-CONVERTING ENZYME I/D POLYMORPHISM AND ARTERIAL-WALL THICKNESS IN A GENERAL-POPULATION - THE VOBARNO STUDY [J].
CASTELLANO, M ;
MUIESAN, ML ;
RIZZONI, D ;
BESCHI, M ;
PASINI, G ;
CINELLI, A ;
SALVETTI, M ;
PORTERI, E ;
BETTONI, G ;
KREUTZ, R ;
LINDPAINTNER, K ;
ROSEI, EA .
CIRCULATION, 1995, 91 (11) :2721-2724
[4]   PATHOGENESIS OF ATHEROSCLEROSIS IN DIABETES-MELLITUS [J].
COLWELL, JA ;
LOPESVIRELLA, M ;
HALUSHKA, PV .
DIABETES CARE, 1981, 4 (01) :121-133
[5]   DIABETES-ASSOCIATED MESENTERIC VASCULAR HYPERTROPHY IS ATTENUATED BY ANGIOTENSIN-CONVERTING ENZYME-INHIBITION [J].
COOPER, ME ;
RUMBLE, J ;
KOMERS, R ;
HECHENG, D ;
JANDELEIT, K ;
SHEUNGTO, C .
DIABETES, 1994, 43 (10) :1221-1228
[6]   ANGIOTENSIN-I-CONVERTING ENZYME IN HUMAN CIRCULATING MONONUCLEAR-CELLS - GENETIC-POLYMORPHISM OF EXPRESSION IN LYMPHOCYTES-T [J].
COSTEROUSSE, O ;
ALLEGRINI, J ;
LOPEZ, M ;
ALHENCGELAS, F .
BIOCHEMICAL JOURNAL, 1993, 290 :33-40
[7]   ANGIOTENSIN-CONVERTING ENZYME IN THE HUMAN HEART - EFFECT OF THE DELETION INSERTION POLYMORPHISM [J].
DANSER, AHJ ;
SCHALEKAMP, MADH ;
BAX, WA ;
VANDENBRINK, AM ;
SAXENA, PR ;
RIEGGER, GAJ ;
SCHUNKERT, H .
CIRCULATION, 1995, 92 (06) :1387-1388
[8]   APOLIPOPROTEIN-E POLYMORPHISM AND ATHEROSCLEROSIS [J].
DAVIGNON, J ;
GREGG, RE ;
SING, CF .
ARTERIOSCLEROSIS, 1988, 8 (01) :1-21
[9]   RELATION OF APOLIPOPROTEIN E PHENOTYPE TO MYOCARDIAL-INFARCTION AND MORTALITY FROM CORONARY-ARTERY DISEASE [J].
EICHNER, JE ;
KULLER, LH ;
ORCHARD, TJ ;
GRANDITS, GA ;
MCCALLUM, LM ;
FERRELL, RE ;
NEATON, JD .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (02) :160-165
[10]   APOLIPOPROTEIN-E POLYMORPHISM AND HYPERLIPEMIA IN TYPE-II DIABETICS [J].
ETO, M ;
WATANABE, K ;
IWASHIMA, Y ;
MORIKAWA, A ;
OSHIMA, E ;
SEKIGUCHI, M ;
ISHII, K .
DIABETES, 1986, 35 (12) :1374-1382